FDA adds warning to Ozempic label about risk for blocked intestines
Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Sep 28, 2023
0
5
Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Sep 28, 2023
0
5
Social media is lighting up over what influencers are calling "budget Ozempic." These are drugs normally used as laxatives and stool softeners, but people are taking them to lose weight. The demand is so high in the United ...
Sep 14, 2023
0
1
When Michel Sadelain began his decades-long quest to genetically modify immune cells to fight cancer, his peers dismissed his ideas as absurd and even his mother grew concerned for his career.
Sep 14, 2023
0
24
Nicotine e-cigarettes and two prescription medications that curb symptoms of withdrawal are the most effective stop-smoking aids, according to a comprehensive, multinational review by a team of scientists, including a University ...
Sep 12, 2023
0
1
A new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer.
Sep 8, 2023
0
3
With three-quarters of Americans obese or overweight, interest in weight-loss treatments is at an all-time high. Three injectable medications have dominated the spotlight of late: Wegovy, Ozempic and Mounjaro. These once-a-week, ...
Sep 8, 2023
0
1
A prominent childhood memory is of my grandparents living with and then dying from dementia. As is universal with dementia, there was a double blow: watching my grandparents lose their identity and seeing the suffering of ...
Sep 1, 2023
0
3
Immediately after COVID-19 vaccination, Danes experienced side effects such as malaise, fever and fatigue. Serious side effects such as facial paralysis and allergic reactions are rare, but 30% of menstruating women reported ...
Aug 29, 2023
0
40
The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.
Aug 27, 2023
0
2
Spain performs more than half of all egg donation treatments across Europe. The country is the largest provider of donor eggs across the continent. And every year, thousands of international fertility patients travel to Spain ...
Aug 17, 2023
0
1